Dr Reddy's API Srikakulam plant gets USFDA nod

Our Bureau Updated - June 03, 2018 at 11:02 AM.

Dr Reddy's Laboratories Ltd has said the USFDA audit of the company's API Srikakulam plant (SEZ) located in Andhra Pradesh, has been completed with no observations. The Hyderabad-based pharma major said this in a regulatory statement to the stock exchanges.

In a recent press conference, the Dr Reddy's management was hopeful of securing approvals for the facility.

Published on June 3, 2018 05:31